about
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease CohortCombination Chemotherapy in Treating Patients With Advanced Colorectal CancerA Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive GlioblastomaProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyA Randomized Trial of Induction Versus Expectant ManagementA Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaPropranolol in Treating Hypoglycemia UnawarenessAn Expanded Access Program of Emicizumab in Participants With Hemophilia A With InhibitorsClinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous InjuryAnemia in the ElderlyConfirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPDDose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas AeruginosaSafety of Sports for Patients With Implantable Cardioverter-DefibrillatorsProspective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)Safety and Tolerability Study of rAvPAL-PEG to Treat PhenylketonuriaA Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform NeurofibromasEfficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismA Study of Flovent in Patients With Eosinophilic EsophagitisA Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis PigmentosaA Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis PigmentosaA Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular DegenerationTrial of Early Aggressive Drug Therapy in Juvenile Idiopathic ArthritisStudy of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular AtrophySafety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher DiseaseMM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast CancerPhase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)Acitretin or Tazarotene Gel and Excimer Laser for Treatment of PsoriasisA Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)Feasibility Study of BMAC Enhanced CABGNickel Allergy With Septal Closure DevicesThe iO-Flex® Study: Evaluation of the Baxano iO-Flex® System for Decompressive Lumbar SurgeryAssess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver FailureDarbe Administration in Newborns Undergoing Cooling for EncephalopathyA Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's DiseaseMindfulness-Based Stress Reduction Techniques and Yoga for Treatment of Urinary Urge Incontinence (MBSR-Yoga)Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic SyndromeExtension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive ImpairmentSTAGES Trial: Study of Adiposity, Growth and Endocrine StagesAllogeneic Heart Stem Cells to Achieve Myocardial RegenerationGilead Sustained Virologic Response (SVR) Registry
P6153
Q37838460-94BBAB58-B4D1-4BB8-B3E3-220C011D2257Q39476018-FC4349E9-C17C-4538-BF19-DB1A54AE7EC5Q47325895-6D081625-CF08-4F01-A59F-515981A182FFQ47818566-FA5F7ABF-F6B6-43BA-A455-F9D01F3421CBQ56452155-5971FA9F-3891-4322-9225-4BDD90C0E253Q57050743-4E6930C9-0796-4DC8-BE4F-5C5884B27607Q57441116-6FA2DB1D-60FA-4B33-A3DF-B6C23708CDB4Q57863157-C52B6916-021A-4494-A2D9-4D5762797A2CQ58821873-A9C396EB-B6CE-4DE3-9DA4-684526635246Q59207957-991407B4-8D14-48E4-8E28-0065190D506FQ59661704-B564B4CB-8FF4-47C1-9F3A-039570FB4C90Q59917077-4FD8BDB9-2EDB-447D-9376-3D848FEE4446
P108
Q45272012-017A7BA1-081B-4EA6-A0EB-7FD69370BAB3Q58407403-CCDE4275-8E6A-4C3F-9BE0-B30DA8D8AE02Q58845806-9458A9E4-F558-4B37-99E3-D759F89446C6Q58848980-060C6D74-1E27-4996-B8F3-70F1E907EF25Q61864782-C25AD0B6-C816-4A4F-A4C4-DF50E9AF2557Q61894391-FFE8A3DA-FC6B-47F3-97EA-59C44242F71EQ61909150-C18025FE-B448-4122-AADF-BCED10526A85Q61909650-67F374C8-7F86-4DD5-8D26-6B13D93FC47AQ61914489-DB9BDE03-567C-43BB-884E-8D1A67D48028Q61914869-FDF03492-A45E-489E-9F8B-4A500E9142E9Q61914922-8CE849FD-A18B-4F46-AF62-2AEED2A346CBQ61915132-A1558480-F2B0-4F35-9603-3025D541CE8EQ61915202-A13B31CF-5617-4851-AA82-73DEB701209BQ61915462-31985D6B-9519-4A14-98C9-C05EF974D0DEQ61915488-59BB89B8-62FC-49C1-BE54-80A0FA1B1F27Q61915528-D0B1C0B8-8EA2-411A-9FD5-45026DA5990CQ61915563-AC3CAE2B-B1B5-42E0-9C0B-0711907F3D6EQ61921444-F9A8605E-4D11-4BDD-A16A-94DFECFBBD7CQ61924249-AAD9075D-8D69-49C1-9346-E232A4A9FEB3Q61924250-AFBB0B5A-A71E-4498-B885-D8232BC0E559Q61924253-C75095AB-2DDA-44E4-906B-386A5D5E554FQ61924872-8E4E29FD-F47B-4406-97F6-6C9DAB7FD5F6Q61932645-AF89A3FE-A0FB-49D0-BA47-E2DFFF631255Q61934429-52C3C7F7-6D7C-4462-8554-7852BF4EBA23Q61936425-9C064A7D-C92F-4DE8-BADC-298E94B4D687Q61936481-533ADD07-CBA2-4550-A8A0-A97829A099C8Q61936743-1E5FC612-A821-4AC3-B2A8-C27A77B6DC85Q61938291-329FEC99-CFD3-4DF4-A1CB-8DB16F486CA7Q61938387-1D69564C-7FAC-47D3-98A2-6548D19E70E5Q61939048-1ECC850A-D791-4D0B-8B04-D9CCD67F7D25Q61939185-70ADADFF-EAA0-4A12-83BD-D3336BC9E5B8Q61955603-D4E8F043-9EB2-4B4C-A1B1-1E0121A19F4EQ61955604-356D7303-66B7-45FD-BDCB-740961E86D6AQ61955645-3A31BB54-985A-4636-A1FC-F45DE80306D8Q61955649-453A992C-4F36-4831-AD5A-294239C7983DQ61955943-5C9F698E-7D1F-44D1-BE1E-389F17C5EDDAQ61956992-1EFBB5C2-B963-4DA1-A5DC-0907BC9C6212Q61957351-339CEA86-0D04-4B97-B169-FBAE5459BDFDQ61965880-876C91C0-23EB-4304-B309-C36F3FB2F917Q61965937-6B7A4360-FC04-441E-9A14-2732D0DC5FAC
P6153
description
healthcare organization in Salt Lake City, United States
@en
name
University of Utah Health Care
@en
type
label
University of Utah Health Care
@en
altLabel
UUHC
@en
prefLabel
University of Utah Health Care
@en
P131
P2427
grid.412722.0
P571
1905-01-01T00:00:00Z
P625
Point (-111.881692 40.852798)